LIN-28A Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-21320
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (96%), Rat (96%). Backed by our 100% Guarantee.
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Summary for LIN-28A Antibody
Immunogen
This antibody was developed against Recombinant Protein corresponding to amino acids: MGSVSNQQFAGGCAKAAEEAPEEAPEDAARAADEPQLLHGAGICKWFNVR
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for LIN-28A Antibody
Immunocytochemistry/Immunofluorescence: LIN-28A Antibody [NBP3-21320] -
Staining of human cell line AF22 shows localization to nucleoli & cytosol.Applications for LIN-28A Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
ICC/IF Fixation Permeabilization: Use PFA/Triton X-100.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, pH 7.2, 40% glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: LIN-28A
Long Name
RNA-binding Protein LIN-28
Alternate Names
CSDD1, LIN28, LIN28A, Tex17, ZCCHC1
Gene Symbol
LIN28A
Additional LIN-28A Products
Product Documents for LIN-28A Antibody
Product Specific Notices for LIN-28A Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...